Return to study ST003362 main page

Download data matrix(Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Reversed phase POSITIVE ION MODE)

Download data matrix(Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Reversed phase NEGATIVE ION MODE)

Download data matrix(Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide HILIC POSITIVE ION MODE)

Download data matrix(Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide HILIC NEGATIVE ION MODE)

Download data matrix(Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase POSITIVE ION MODEU251_Control_1_POSTreatment:ControlCounts
Reversed phase POSITIVE ION MODEU251_Control_2_POSTreatment:ControlCounts
Reversed phase POSITIVE ION MODEU251_Control_3_POSTreatment:ControlCounts
Reversed phase POSITIVE ION MODEU251_Control_4_POSTreatment:ControlCounts
Reversed phase POSITIVE ION MODEU251_Pimozide_1_POSTreatment:PimozideCounts
Reversed phase POSITIVE ION MODEU251_Pimozide_2_POSTreatment:PimozideCounts
Reversed phase POSITIVE ION MODEU251_Pimozide_3_POSTreatment:PimozideCounts
Reversed phase POSITIVE ION MODEU251_Pimozide_4_POSTreatment:PimozideCounts
Reversed phase NEGATIVE ION MODEU251_Control_1_NEGTreatment:ControlCounts
Reversed phase NEGATIVE ION MODEU251_Control_2_NEGTreatment:ControlCounts
Reversed phase NEGATIVE ION MODEU251_Control_3_NEGTreatment:ControlCounts
Reversed phase NEGATIVE ION MODEU251_Control_4_NEGTreatment:ControlCounts
Reversed phase NEGATIVE ION MODEU251_Pimozide_1_NEGTreatment:PimozideCounts
Reversed phase NEGATIVE ION MODEU251_Pimozide_2_NEGTreatment:PimozideCounts
Reversed phase NEGATIVE ION MODEU251_Pimozide_3_NEGTreatment:PimozideCounts
Reversed phase NEGATIVE ION MODEU251_Pimozide_4_NEGTreatment:PimozideCounts
HILIC POSITIVE ION MODEU251_Control_1_POSTreatment:ControlCounts
HILIC POSITIVE ION MODEU251_Control_2_POSTreatment:ControlCounts
HILIC POSITIVE ION MODEU251_Control_3_POSTreatment:ControlCounts
HILIC POSITIVE ION MODEU251_Control_4_POSTreatment:ControlCounts
HILIC POSITIVE ION MODEU251_Pimozide_1_POSTreatment:PimozideCounts
HILIC POSITIVE ION MODEU251_Pimozide_2_POSTreatment:PimozideCounts
HILIC POSITIVE ION MODEU251_Pimozide_3_POSTreatment:PimozideCounts
HILIC POSITIVE ION MODEU251_Pimozide_4_POSTreatment:PimozideCounts
HILIC NEGATIVE ION MODEU251_Control_1_NEGTreatment:ControlCounts
HILIC NEGATIVE ION MODEU251_Control_2_NEGTreatment:ControlCounts
HILIC NEGATIVE ION MODEU251_Control_3_NEGTreatment:ControlCounts
HILIC NEGATIVE ION MODEU251_Control_4_NEGTreatment:ControlCounts
HILIC NEGATIVE ION MODEU251_Pimozide_1_NEGTreatment:PimozideCounts
HILIC NEGATIVE ION MODEU251_Pimozide_2_NEGTreatment:PimozideCounts
HILIC NEGATIVE ION MODEU251_Pimozide_3_NEGTreatment:PimozideCounts
HILIC NEGATIVE ION MODEU251_Pimozide_4_NEGTreatment:PimozideCounts
Reversed phase NEGATIVE ION MODELCFA_Control_1Treatment:ControlCounts
Reversed phase NEGATIVE ION MODELCFA_Control_2Treatment:ControlCounts
Reversed phase NEGATIVE ION MODELCFA_Control_3Treatment:ControlCounts
Reversed phase NEGATIVE ION MODELCFA_Control_4Treatment:ControlCounts
Reversed phase NEGATIVE ION MODELCFA_Pimozide_1Treatment:PimozideCounts
Reversed phase NEGATIVE ION MODELCFA_Pimozide_2Treatment:PimozideCounts
Reversed phase NEGATIVE ION MODELCFA_Pimozide_3Treatment:PimozideCounts
Reversed phase NEGATIVE ION MODELCFA_Pimozide_4Treatment:PimozideCounts
  logo